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In Vitro Susceptibility Profiles of
Methods. We reviewed microbiology records to determine the number of patients with cultures growing CS from 1/1/14 to 12/31/16. Prior to 11/2015, diphtheroids identified from sterile body sites were sent to a reference lab for identification (ID); beginning in 11/2015, MALDI-TOF was used by the microbiology lab for CS ID. Two infectious diseases physicians reviewed charts of all 2016 cases using a standardized data collection tool and determined whether patients had infection vs. colonization.
Results. We identified 3,6, and 50 patients with cultures growing CS in 2014, 2015, and 2016, respectively. Thirty-six (72%) of the patients in 2016 were felt to have true infection. Skin and soft-tissue infections and osteomyelitis were the most common sites (Figure) . The majority of infected patients were immunocompetent, had community-acquired (CA) infections, received antibiotics in the prior 60 days, and required prolonged courses of antimicrobial treatment (Table) . No epidemiologic link was identified for nosocomial or CA infections.
Conclusion. The notable increase in clinically significant CS infections at our institution warrants further investigation. Whole genome sequencing may offer insight into whether a specific clone is responsible for more invasive disease. 
